Lipid Metabolism and Statin Therapy in Neurodegenerative Diseases: An Endocrine View
<b>Background/aim</b>: A growing body of evidence suggests a link between dyslipidemias and neurodegenerative diseases, highlighting the crucial role of lipid metabolism in the health of the central nervous system. The aim of our work was to provide an update on this topic, with a focus...
Saved in:
| Main Authors: | Antonella Di Sarno, Fiammetta Romano, Rossana Arianna, Domenico Serpico, Mariarosaria Lavorgna, Silvia Savastano, Annamaria Colao, Carolina Di Somma |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-04-01
|
| Series: | Metabolites |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2218-1989/15/4/282 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
STATINS AND RISK OF INFECTIOUS DISEASES
by: O. M. Drapkina, et al.
Published: (2015-09-01) -
Statin Intolerance and Adverse Effects in Lipid-Lowering Therapy – Pathomechanisms, Management Strategies, and Alternative Treatment Approaches
by: Natalia Śliwa, et al.
Published: (2025-06-01) -
Nutraceutical Strategies for Targeting Mitochondrial Dysfunction in Neurodegenerative Diseases
by: Federica Davì, et al.
Published: (2025-06-01) -
Melatonin—A Powerful Antioxidant in Neurodegenerative Diseases
by: Renata Kołodziejska, et al.
Published: (2025-07-01) -
Statin therapy for NAFLD: Molecular underpinnings of myopathic consequences and treatment strategies
by: Pratiksha Nanepag, et al.
Published: (2025-06-01)